Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
08/1998
08/26/1998EP0860422A1 Derivatives of benzylidene cyclohexanone, benzylidene cyclopentanone, and benzylidene acetone and their synthesis.
08/26/1998EP0859834A2 A paf-acetylhydrolase and use in therapy
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859784A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
08/26/1998EP0859771A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
08/26/1998EP0859769A1 Esters of non-steroidal anti-inflammatory carboxylic acids
08/26/1998EP0859766A1 Chiral methyl phenyl oxazolidinones
08/26/1998EP0859622A1 Extracts of shark cartilage
08/26/1998EP0859607A1 Guanidino protease inhibitors
08/26/1998EP0859603A1 Sustained release matrix for high-dose insoluble drugs
08/26/1998EP0741715B1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
08/26/1998EP0739336B1 Gem-disubstituted azacyclic tachykinin antagonists
08/26/1998EP0656015B1 New nimesulide salt cyclodextrin inclusion complexes
08/26/1998EP0423326B1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
08/26/1998CN1191533A 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivs. as neurokinin receptor antagonists
08/26/1998CN1191492A Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/25/1998US5798389 Administering docosahexaenoic acid and it's derivative for treating autoimmune disease, kidney disorder and side effect reduction
08/25/1998US5798383 Prevention of an inflammatory disease, allergy or cardiovascular disease for which a 5-lipoxygenase inhibitor is needed
08/25/1998US5798373 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
08/25/1998US5798352 Antithrombotic amidinotetrahydropyridylalanine derivatives
08/25/1998US5798335 Administration of peptide t
08/25/1998US5798332 Inhibiting thrombosis by administering reagent that binds carbohydrate in which sialic acid is linked to galactose or n-acetylgalactosamine through alpha2-6 linkage
08/25/1998US5798246 Cyclic nucleotide phosphodiesterase
08/25/1998US5798213 Monoclonal antibodies
08/25/1998CA2224111A1 Novel compounds
08/25/1998CA2122479C Risedronate delayed-release compositions
08/20/1998WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION
08/20/1998WO1998035967A2 Biazacyclic crf antagonists
08/20/1998WO1998035966A1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
08/20/1998WO1998035949A1 Bicyclic amino acids
08/20/1998WO1998025584A3 Cosmetic preparation with a peptide addition
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998DE19712659C1 Use of Alchemilla vulgaris extract as angiogenesis inhibitor
08/20/1998DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/19/1998EP0859054A1 Drug binding protein
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859000A1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858451A1 Pharmaceutically active quinazoline compounds
08/19/1998EP0858444A1 Cyclopentyl tachykinin receptor antagonists
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858329A1 Novel stable liquid paracetamol compositions, and method for preparing same
08/19/1998EP0618809B1 Bradykinin type peptides
08/19/1998EP0460058B1 Use of bactericidal/permeability increasing protein or biologically active analogs thereof for the manufacture of a medicament to treat endotoxin-associated disorders
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190970A Resolution of 1-azabicyclo £2.2.2| octan-3-amine, 2-(diphenylmethyl)-N-££2-methoxy-5-(1-methylethyl) phenyl| methyl|
08/19/1998CN1190891A Use of di-beta-D-glucopyranosylamine compounds for controlling inflammatory reactions, and method of systnesis
08/19/1998CN1190890A Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
08/19/1998CA2223020A1 Human protein kinase hoacf72
08/18/1998US5795905 CRF receptor antagonists and methods relating thereto
08/18/1998US5795888 Analgesics, antiinflammatory agents, antidiabetic agents
08/18/1998US5795875 Therapeutic methods of using O-desulfated heparin derivatives
08/18/1998US5795865 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
08/18/1998US5795859 Peptide which abrogates TNF and/or LPS toxicity
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/18/1998CA2224123A1 Nucleic acid construct for the cell cycle regulated expression of structural genes
08/18/1998CA2215920A1 Drug binding protein
08/13/1998WO1998035056A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998WO1998034959A1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation
08/13/1998WO1998034919A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/13/1998WO1998034909A1 Bi-aromatic compounds, compositions containing them and uses
08/13/1998WO1998034644A1 Compositions and articles for reducing the effects of inflammation
08/13/1998WO1998034629A1 Process for preparing synthetic soil-extract materials and medicaments based thereon
08/13/1998WO1998034614A1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
08/13/1998WO1998022501A3 Secreted proteins and polynucleotides encoding them
08/13/1998WO1998018466A3 Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
08/13/1998CA2277544A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998CA2253221A1 Bi-aromatic compounds, compositions containing them and uses
08/12/1998EP0857781A2 Human endoglingene promoter and use thereof
08/12/1998EP0857175A1 Novel human cysteine protease
08/12/1998EP0741687B1 Leukotriene b4 derivatives, methods of preparing them and their use as drugs
08/12/1998EP0696275B1 Vitamin d amide derivatives
08/12/1998EP0689538B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
08/12/1998EP0566709B1 Composition comprising a tramadol compound and acetaminophen, and its use
08/12/1998EP0556207B1 Modified human tnfalpha (tumor necrosis factor alpha) receptor
08/12/1998CN1190401A C-4' modified adenosine kinase inhibitor
08/12/1998CN1190393A Diaryldiamine derivatives and their use as delta opioid (ANT)-agonists
08/12/1998CN1190096A Compounds analogous to thalidomide from class comprising piperidine-2,6-diones
08/12/1998CN1190017A Zhengzhong rheumatism expelling pellet
08/11/1998US5792882 5-lipoxygenase inhibitors, antiallergens, antiinflammatory agents
08/11/1998US5792845 Nucleotides encoding angiostatin protein and method of use
08/11/1998US5792797 Pharmaceutical compounds
08/11/1998US5792786 Sustained and prolonged wound healing agents
08/11/1998US5792783 Capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
08/11/1998US5792772 Enatiomerically pure hydroxylated xanthine compounds
08/11/1998US5792770 Administering as sedative, tranquilizer, anxiolytic agent
08/11/1998US5792758 Steroid nitrite ester derivatives useful as anti-inflammatory drugs
08/11/1998US5792629 Nucleotide and amino acid sequences
08/11/1998US5792457 Antibody recognizing endothelial cell ligand for leukocyte CR3
08/11/1998US5792444 Labeled chemotactic peptides to image focal sites of infection or inflammation
08/11/1998CA2064160C Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
08/06/1998WO1998033922A1 The neurotrophic factor nnt-1
08/06/1998WO1998033916A2 Secreted proteins and polynucleotides encoding them
08/06/1998WO1998033908A1 Human c5a-like receptor
08/06/1998WO1998033811A1 Peptides comprising a t-cell epitope specific to collagen ii
08/06/1998WO1998033797A1 Pyrrolidine derivatives having phospholipase a2 inhibitory activity
08/06/1998WO1998033788A1 Matrix metalloproteinase inhibitors
08/06/1998WO1998033769A1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii